FDA approves Ferring’s CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral solution for colonoscopy prep
-The U.S. Food and Drug Administration (FDA) has granted Ferring Pharmaceuticals Inc. approval to market CLENPIQ™ (sodium picosulfate,…
New Ferring and Aché Laboratórios Farmacêuticos facility opens to optimise drug delivery using nanotechnology
-Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos today announced the inauguration of their joint nanotechnology centre in São Paulo…
Ferring receives Swiss approval for Rekovelle®, the first personalised fertility treatment using an approved dosing algorithm
-Ferring Pharmaceuticals announced today that Swissmedic has approved Rekovelle® (follitropin delta) for use in controlled stimulation…
Ferring strengthens growth hormone franchise Zomacton® through acquisition of ZomaJet™ needle-free injector device
-Ferring Pharmaceuticals announced today that it has entered into a definitive agreement with Antares Pharma, Inc…
Ferring appoints Klaus Dugi as Executive Vice President and Chief Medical Officer
-Ferring Pharmaceuticals announced today that Professor Klaus Dugi has been appointed Executive Vice President and Chief Medical Officer…
